What's The BUZZ?

Market News, Products, Services, and Trends

5 Key Challenges the Revisions to USP Will Pose for Pharmacies that Create Category 3 Compounded Sterile Preparations

1694019373390.jpg


The revised USP <797> standards for pharmacies that create Category 3 compounded sterile preparations (CSPs), which become enforceable on November 1, 2023, will pose a set of unique challenges to overcome in order to ensure compliance. These challenges will change the way pharmacies train their personnel, monitor surfaces, test for sterility, and more. Thankfully, AIS Healthcare is ready for the USP <797> revisions…are you?


Learn how our pharmacies meet the revised USP <797> standards or contact us. We’re here to help. 

AIS Healthcare

AIS Healthcare News & Announcements

AIS Healthcare is a leader in targeted drug delivery and infusion care, empowering transformative impact across the care continuum.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from 5 Key Challenges the Revisions to USP Will Pose for Pharmacies that Create Category 3 Compounded Sterile Preparations

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe